- Visibility 354 Views
- Downloads 308 Downloads
- Permissions
- DOI 10.18231/j.ijnmhs.2025.013
-
CrossMark
Nutritional supplementation and its role in Indian women's health: An expert perspective study
- Author Details:
-
Manjula S *
-
Krishna Kumar M
Manjula S *
Krishna Kumar M
Background: Although there are several studies regarding nutritional supplements, there is a dearth of specific data regarding multivitamin use among experts in Indian contexts. So, this study gathers expert perspectives on women's awareness and nutritional supplementation needs across different life stages, with a focus on pregnancy, lactation, polycystic ovary syndrome (PCOS) management, and the use of myo-inositol (MI) and D-chiro-inositol (DCI) in Indian settings.
Materials and Methods: This cross-sectional study was conducted among Indian experts using a 23-item questionnaire designed to assess nutritional practices. The questions covered topics such as patient awareness, protein requirements, pregnancy care, PCOS management, and supplement adherence. The effectiveness of MI–DCI supplementation was also evaluated. Descriptive statistics were used to analyse the data.
Results: The study included 63 experts, of whom 92% reported that pregnant and lactating women most commonly require protein supplementation. Among them, 38% recommended protein supplementation to 51–75% of their patients. Low haemoglobin levels (Hb <9>
Conclusion: The study findings are consistent with existing literature on micronutrient deficiencies in Indian women and support the clinical efficacy of the 40:1 MI–DCI ratio in enhancing ovarian function and improving reproductive outcomes in women with PCOS.
Keywords: Nutrition, Supplementation, Pregnancy, Polycystic ovary syndrome, Myo-inositol, D-chiro-inositol
References
- Chea N, Tegene Y, Astatkie A, Spigt M. Prevalence of undernutrition among pregnant women and its differences across relevant subgroups in rural Ethiopia: a community-based cross-sectional study. J Health Popul Nutr. 2023;42(1):17.
- Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, et al. Maternal and child undernutrition and overweight in low- income and middle-income countries. Lancet. 2013;382(9890):427–
- Ali A, Sen S, Banerjee A, Chakma N. Rural-urban differentials in undernutrition among women in India: Evidence from a decomposition approach. Nutr Health. 2024; 2601060241292401.
- Marshall NE, Abrams B, Barbour LA, Catalano P, Christian P, Friedman JE, et al. The importance of nutrition in pregnancy and lactation: lifelong consequences. Am J Obstet Gynecol. 2022;226(5):607–32.
- Shirisha P, Muraleedharan VR, Vaidyanathan G. Wealth related inequality in women and children malnutrition in the state of Chhattisgarh and Tamil Nadu. BMC Nutr. 2022;8(1):86.
- Rai RK, Kumar SS, Parasannanavar DJ, Khandelwal S, Rajkumar H. Tipping the scale: the role of a national nutritional supplementation programme for pregnant mothers in reducing low birth weight and neonatal mortality in India. Br J Nutr. 2022;127(2):289–97.
- World Health Organization. Polycystic ovary syndrome [Internet]. Available from: https://www.who.int/news-room/fact- sheets/detail/polycystic-ovary-syndrome [Accessed on 2025 Apr 15]
- “Polycystic Ovarian Syndrome (PCOS) and its Complications” [Internet]. Available from: https://www.pib.gov.in/Pressreleaseshare.aspx?PRID=1893279
- Lete I, Martínez A, Lasaga I, Centurión E, Vesga A. Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome. Gynecol Endocrinol. 2024;40(1):2301554.
- Kalra B, Kalra S, Sharma JB. The inositols and polycystic ovary syndrome. Indian J Endocrinol Metab. 2016;20(5):720–4.
- Balanced energy and protein supplementation during pregnancy [Internet]. Available from: https://www.who.int/tools/elena/interventions/energy-protein- pregnancy [Accessed on 2023 Aug 9]
- Liberato SC, Singh G, Mulholland K. Effects of protein energy supplementation during pregnancy on fetal growth: a review of the literature focusing on contextual factors. Food Nutr Res. 2013;57.
- Murphy MM, Higgins KA, Bi X, Barraj LM. Adequacy and Sources of Protein Intake among Pregnant Women in the United States, NHANES 2003-2012. Nutrients. 2021;13(3):795.
- Barman M. Anaemia prevalence and socio-demographic factors among women of reproductive age (WRA): A geospatial analysis of Manjula and Kumar/ IP Journal of Nutrition, Metabolism and Health Science 2025;8(2):60–65 65 empowered action group (EAG) states in India. Spat Spatiotemporal Epidemiol. 2024;49:100644.
- Let S, Tiwari S, Singh A, Chakrabarty M. Prevalence and determinants of anaemia among women of reproductive age in Aspirational Districts of India: an analysis of NFHS 4 and NFHS 5 data. BMC Public Health. 2024;24(1):437.
- Barney AM, Abraham VJ, Danda S, Cherian AG, Vanitha S. Prevalence of Vitamin B12 Deficiency and Its Associated Risk Factors among Pregnant Women of Rural South India: A Community-based Cross-sectional Study. Indian J Community Med. 2020;45(4):399–404.
- Pandey M, Singh S, Attri M. Screening and prevalence of vitamin B12 deficiency among pregnant women. Int J Reprod Contracept Obstet Gynecol. 2022;11(8):2112–6.
- Sundarakumar JS, Shahul Hameed SK, Ravindranath V. Burden of Vitamin D, Vitamin B12 and Folic Acid Deficiencies in an Aging, Rural Indian Community. Front Public Health. 2021;9:707036.
- Haneef DS, Lalitha DK, Poulose DKP. Prevalence of vitamin D deficiency among pregnant women attending a tertiary care centre in South India. Ind Obstet Gynaecol. 2022;12(2):9–14.
- Nordio M, Basciani S, Camajani E. The 40:1 myo-inositol/D-chiro- inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. Eur Rev Med Pharmacol Sci. 2019;23(12):5512–21.
- Bevilacqua A, Dragotto J, Giuliani A, Bizzarri M. Myo-inositol and D-chiro-inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model. J Cell Physiol. 2019;234(6):9387–98.
- Colak E, Ozcimen EE, Tohma YA, Ceran MU. May myo-inositol and d-chiro-inositol (40:1) treatment be a good option on normal- weighted polycystic ovary syndrome patients without insulin resistance? J Obstet Gynaecol Res. 2020;46(12):2605–11.
- Colazingari S, Treglia M, Najjar R, Bevilacqua A. The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro- inositol, is able to improve IVF outcomes: results from a randomized controlled trial. Arch Gynecol Obstet. 2013;288(6):1405–11.
- Kachhawa G, Kumar KVS, Kulshrestha V, Khadgawat R, Mahey R, Bhatla N. Efficacy of myo-inositol and d-chiro-inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: A randomized open- label study. Int J Gynaecol Obstet. 2022;158(2):278–84.
- Benelli E, Del Ghianda S, Di Cosmo C, Tonacchera M. A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women. Int J Endocrinol. 2016;2016:3204083.
- Mohammadi S, Eini F, Bazarganipour F, Taghavi SA, Kutenaee MA. The effect of Myo-inositol on fertility rates in poor ovarian responder in women undergoing assisted reproductive technique: a randomized clinical trial. Reprod Biol Endocrinol. 2021;19(1):61.
- Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med. 1999;340(17):1314–20.
- Iuorno MJ, Jakubowicz DJ, Baillargeon JP, Dillon P, Gunn RD, Allan G, et al. Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome. Endocr Pract. 2002;8(6):417–23.